Lymphoma, Large-Cell, Anaplastic
"Lymphoma, Large-Cell, Anaplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called "hallmark" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.
MeSH Number(s)
C04.557.386.480.487
C04.557.386.480.750.399
C15.604.515.569.480.487
C20.683.515.761.480.750.399
Concept/Terms
Lymphoma, Large-Cell, Anaplastic- Lymphoma, Large-Cell, Anaplastic
- CD30-Positive Anaplastic Large-Cell Lymphoma
- CD30 Positive Anaplastic Large Cell Lymphoma
- Ki-1 Lymphoma
- Ki 1 Lymphoma
- Ki-1 Lymphomas
- Lymphoma, Ki-1
- Lymphomas, Ki-1
- Systemic Anaplastic Large-Cell Lymphoma
- Systemic Anaplastic Large Cell Lymphoma
- Anaplastic Large-Cell Lymphoma
- Anaplastic Large Cell Lymphoma
- Anaplastic Large-Cell Lymphomas
- Large-Cell Lymphoma, Anaplastic
- Large-Cell Lymphomas, Anaplastic
- Lymphoma, Anaplastic Large-Cell
- Lymphomas, Anaplastic Large-Cell
- CD30+ Anaplastic Large-Cell Lymphoma
- CD30+ Anaplastic Large Cell Lymphoma
- Lymphoma, Large-Cell, Ki-1
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Large-Cell, Anaplastic".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, Large-Cell, Anaplastic [C04.557.386.480.487]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, Large-Cell, Anaplastic [C04.557.386.480.750.399]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, Large-Cell, Anaplastic [C15.604.515.569.480.487]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, Large-Cell, Anaplastic [C20.683.515.761.480.750.399]
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Large-Cell, Anaplastic".
This graph shows the total number of publications written about "Lymphoma, Large-Cell, Anaplastic" by people in Harvard Catalyst Profiles by year, and whether "Lymphoma, Large-Cell, Anaplastic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 3 | 3 |
| 2002 | 2 | 0 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 6 | 0 | 6 |
| 2009 | 3 | 1 | 4 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 6 | 1 | 7 |
| 2014 | 4 | 3 | 7 |
| 2015 | 7 | 1 | 8 |
| 2016 | 1 | 1 | 2 |
| 2017 | 4 | 1 | 5 |
| 2018 | 2 | 0 | 2 |
| 2019 | 6 | 1 | 7 |
| 2020 | 6 | 1 | 7 |
| 2021 | 9 | 1 | 10 |
| 2022 | 7 | 0 | 7 |
| 2023 | 3 | 0 | 3 |
Below are the most recent publications written about "Lymphoma, Large-Cell, Anaplastic" by people in Profiles.
-
MiR-146a-5p enrichment in small-extracellular vesicles of relapsed pediatric ALCL patients promotes macrophages infiltration and differentiation. Biochem Pharmacol. 2023 09; 215:115747.
-
Targeting CCR7-PI3K? overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. Sci Transl Med. 2023 06 28; 15(702):eabo3826.
-
Plasma small-extracellular vesicles enriched in miR-122-5p promote disease aggressiveness in pediatric anaplastic large-cell lymphoma. Cancer Commun (Lond). 2023 05; 43(5):630-634.
-
TCL-318 Evaluation of the Antitumor Activity of Amiloride in Peripheral T-Cell Lymphomas Using In-Vitro Models. Clin Lymphoma Myeloma Leuk. 2022 Oct; 22 Suppl 2:S399.
-
Pseudocarcinomatous Hyperplasia Masquerading as a Well-Differentiated Squamous Cell Carcinoma Associated With Primary Cutaneous Anaplastic Large-Cell Lymphoma. Am J Dermatopathol. 2022 Dec 01; 44(12):952-954.
-
PDGFRß promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma. Mol Cancer. 2022 08 31; 21(1):172.
-
Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK Positive. Am J Clin Pathol. 2022 08 04; 158(2):300-310.
-
Breast Implant Capsule-Associated Squamous Cell Carcinoma: Report of 2 Patients. Int J Surg Pathol. 2022 Dec; 30(8):900-907.
-
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. Blood. 2022 02 03; 139(5):717-731.
-
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant. Br J Haematol. 2022 04; 197(2):212-222.